Rayence, Q1 2021, Sales Results (Provisional)

Image credit: Rayence booth RSNA 2017, Rayence US

On 10th May, Rayence Corporation published its provisional financial results for Q1 2021. These results show that quarterly sales returned to growth following four consecutive quarters of sales decline. Group quarterly sales reached ₩31.5 bn, compared with ₩27.2 bn during Q1 2020, an increase of approximately +16% year-on-year.

SubsidiaryIncorporationControl
Rayence IncUSA100%
OSKO IncUSA80.65%
OSKO MEXMexico100%
WoorienKorea92.31%
Rayence & MyVetUSA92.31%
QpixUSA100%
A-PharmKorea63.02%
P&VKorea41.75%
Rayence ChinaChina100%

Subscribe

Processing…
Success! You're on the list.